Michael Mason's Net Worth

$8.59 Million

Estimate Recalculated Nov 7, 2024 12:13PM EST

Who is Michael Mason?

Michael Mason has an estimated net worth of $8.59 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., and Karyopharm Therapeutics Inc..

SEC CIK

Michael Mason's CIK is 0001514291

Past Insider Trading and Trends

2018 was Michael Mason's most active year for acquiring shares with 15 total transactions. Michael Mason's most active month to acquire stocks was the month of November. 2013 was Michael Mason's most active year for disposing of shares, totalling 20 transactions. Michael Mason's most active month to dispose stocks was the month of November. 2018 saw Michael Mason paying a total of $2,804,910.51 for 46,196 shares, this is the most they've acquired in one year. In 2018 Michael Mason cashed out on 68,975 shares for a total of $4,876,007.21, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $246.78

VP, Finance and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 27
Form 4
—
0
—
—
0
Aug 21
Form 4
+271.24%
613
$90.95
-$40,836.55
839
Jan 17 - Aug 13
Form 4
—
0
—
—
0
Mar 1
Form 4
-100.00%
-4.96K
$109.93
-$2,030,260.15
0
Scheduled
Jan 4
Form 4
∞
4.96K
$127.05
-$449,502.90
4.96K
Dec 30
Form 4
—
0
—
—
0
Dec 20
Form 4
—
0
—
—
0
Nov 6
Form 4
—
0
—
—
0
Sep 20
Form 4
—
0
—
—
0
Jul 7
Form 4
—
0
$42.02
-$524,662.50
0
Scheduled
May 16
Form 4
—
0
—
—
0
Dec 30
Form 4
—
0
—
—
0
Dec 20
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Dec 18
Form 4
—
0
—
—
0
Dec 7
Form 4
—
0
$88.94
-$411,120.65
0
Scheduled
Jun 1
Form 4
—
0
—
—
0
May 1
Form 4
-100.00%
-1.54K
$54.50
-$1,923,691.88
0
Scheduled
Dec 12 - Dec 15
Form 4
-70.93%
-3.75K
$78.66
-$294,992.48
1.54K
Scheduled
Feb 3
Form 4
-32.62%
-2.56K
$89.49
-$229,094.40
5.29K
Jan 23
Form 4
—
0
$36.46
-$382,362.38
7.85K
Scheduled
Dec 16 - Dec 18
Form 4
—
0
$34.46
-$205,237.63
7.85K
Scheduled
Dec 2
Form 4
—
0
$40.70
-$264,262.00
7.85K
Scheduled
Jul 12
Form 4
—
0
$27.07
-$266,550.00
7.85K
Scheduled
Jul 1
Form 4
—
0
$21.79
-$384,957.54
7.85K
Scheduled
Jun 17
Form 4
—
0
—
—
0
Dec 20
Form 4
—
0
$12.02
-$36,847.12
7.85K
Scheduled
Nov 30
Form 4
—
0
$15.49
-$56,375.00
7.85K
Scheduled
Jul 27
Form 4
—
0
$14.99
-$109,489.36
7.85K
Scheduled
Jul 16
Form 4
∞
7.85K
—
—
7.85K
Jan 23
Form 4
—
0
—
—
0
Nov 30
Form 4
—
0
—
—
0
Feb 28
Form 3
—
0
—
—
0
No matching records found

Karyopharm Therapeutics Inc. (KPTI) Snapshot price: $0.77

EVP, CFO & Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.77%
-7.05K
$0.72
-$5,088.69
391.05K
Sep 4
Form 4
-0.16%
-652.00
$0.99
-$645.48
398.1K
Jun 4
Form 4
-7.82%
-33.85K
$1.18
-$39,788.19
398.76K
Feb 29 - Mar 1
Form 4
+75.18%
185.66K
$1.32
-$3,369.07
432.61K
Feb 27 - Feb 28
Form 4
-1.67%
-4.21K
$1.59
-$6,671.23
246.94K
Feb 6
Form 4
+5.61%
13.33K
—
—
251.15K
Jan 24
Form 4
-2.82%
-6.91K
$1.33
-$9,203.28
237.82K
Sep 1
Form 4
-0.26%
-631.00
$2.22
-$1,400.82
244.73K
Jun 2
Form 4
+51.86%
83.8K
$3.03
-$33,942.19
245.36K
Feb 28 - Mar 1
Form 4
-1.70%
-2.80K
$3.04
-$8,509.11
161.57K
Feb 27
Form 4
-2.46%
-4.14K
$3.40
-$14,079.40
164.37K
Feb 6
Form 4
+21.66%
30K
—
—
168.51K
Aug 31
Form 4
-0.43%
-601.00
$6.04
-$3,630.12
138.51K
Jun 3
Form 4
+160.96%
85.8K
$10.24
-$24,549.52
139.11K
Feb 28
Form 4
-6.89%
-3.95K
$9.86
-$38,925.31
53.31K
Feb 7
Form 4
+10.63%
5.5K
—
—
57.26K
Jun 1
Form 4
+74.01%
22.01K
—
—
51.76K
Feb 25
Form 4
-35.07%
-2.86K
$15.52
-$44,353.59
5.29K
Feb 11
Form 4
∞
8.15K
—
—
8.15K
Feb 5
Form 4
—
0
—
—
0
Feb 5
Form 4
—
0
—
—
0
Feb 25
Form 3
—
0
—
—
0
No matching records found